XML 59 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in two business segments, the Specialty Products & Technologies and Equipment & Consumables segments. The Company’s Specialty Products & Technologies products primarily include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products primarily include traditional consumable products such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products primarily include digital imaging systems, software and other visualization and magnification systems.

On December 31 2024, the Company adopted ASU 2023-07, “Segment Reporting - Improving Reportable Segment Disclosures” and updated its disclosures to conform to the new segment disclosure requirements. Additionally, prior year disclosures have been modified to conform to the new ASU disclosure presentation requirements. There were no changes to significant expense classifications nor the methods used to allocate such expenses, and therefore recasting of segment information for the years ended December 31, 2023 and 2022 is not required.

The Company’s operating segments are also its reportable segments. The Company’s CODM is the chief executive officer. The CODM primarily utilizes segment operating profit or loss as the key indicator in assessing the segment's performance and allocating resources. Operating profit represents total revenues less expenses, excluding corporate and other expenses, nonoperating income (expense), interest expense and income taxes. The expense components used in determining operating profit include the following:

Cost of sales which include the cost of materials, labor, facilities, restructuring costs and other infrastructure used to manufacture the Company’s products, and shipping and handling costs attributable to delivering these products to customers.

Selling, general and administrative (“SG&A”) expenses which includes, among other things, the costs of selling, marketing, promotion, advertising and administration (including business technology, facilities, legal, finance, human resources, business development and procurement), restructuring and amortization expense for intangible assets that have been acquired through business combinations.

Research and development (“R&D”) expenses which include project costs specific to new product R&D and product lifecycle management, overhead costs associated with R&D operations, regulatory costs, product registrations and investments that support local market clinical trials for approved indications.

For corporate and other, these expenses represent unallocated corporate costs and other costs, including goodwill and intangible impairment charges. These activities do not meet the criteria for a stand-alone reporting segment under ASC 280 Segment Reporting, thus are not considered in management’s evaluation of reportable segment operating performance.

The identifiable assets by segment are those used in each segment’s operations. Additionally, inter-segment amounts which have been eliminated, are not significant to the below presentation of segment information.
Segment related information is shown below ($ in millions):
Year Ended December 31, 2024
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Sales$1,616.4 $894.2 $2,510.6 
Less:
Expenses1,526.5 741.9 2,268.4 
Segment operating profit$89.9 $152.3 $242.2 
Segment operating profit and reconciliation to loss before taxes:
Segment operating profit$242.2 
Corporate and other(1,280.4)
Nonoperating other expense, net(0.1)
Interest expense, net(46.4)
Loss before taxes$(1,084.7)
Depreciation and amortization
Specialty Products & Technologies$85.1 
Equipment & Consumables35.9 
Corporate and other2.1 
Total$123.1 
Capital expenditures, gross
Specialty Products & Technologies$20.4 
Equipment & Consumables10.5 
Corporate and other3.2 
Total$34.1 
Identifiable assets
Specialty Products & Technologies$2,354.2 
Equipment & Consumables1,884.2 
Corporate and other1,112.1 
Total$5,350.5 
Year Ended December 31, 2023
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Sales$1,642.4 $924.1 $2,566.5 
Less:
Expenses1,410.3 767.8 2,178.1 
Segment operating profit$232.1 $156.3 $388.4 
Segment operating profit and reconciliation to loss before taxes:
Segment operating profit$388.4 
Corporate and other(356.9)
Nonoperating other expense, net(23.0)
Interest expense, net(63.4)
Loss before taxes$(54.9)
Depreciation and amortization
Specialty Products & Technologies$86.1 
Equipment & Consumables47.2 
Corporate and other2.3 
Total$135.6 
Capital expenditures, gross
Specialty Products & Technologies$39.0 
Equipment & Consumables12.3 
Corporate and other1.9 
Total$53.2 
Identifiable assets
Specialty Products & Technologies$3,277.7 
Equipment & Consumables2,338.6 
Corporate and other988.8 
Total$6,605.1 
Year Ended December 31, 2022
Specialty Products & TechnologiesEquipment & ConsumablesTotal
Sales$1,598.6 $970.5 $2,569.1 
Less:
Expenses 1,330.0 798.1 2,128.1 
Segment operating profit$268.6 $172.4 $441.0 
Segment operating profit and reconciliation to loss before taxes:
Segment operating profit$441.0 
Corporate and other(121.8)
Nonoperating other income, net3.1 
Interest expense, net(38.4)
Income before taxes$283.9 
Depreciation and amortization
Specialty Products & Technologies$80.7 
Equipment & Consumables54.6 
Corporate and other2.5 
Total$137.8 
Capital expenditures, gross
Specialty Products & Technologies$48.8 
Equipment & Consumables20.6 
Corporate and other2.7 
Total$72.1 
Operations in Geographical Areas:
Year Ended December 31,
($ in millions)202420232022
Sales:
United States$1,202.9 $1,209.4 $1,261.9 
China193.5 205.7 222.2 
All other (each country individually less than 5% of total sales)1,114.2 1,151.4 1,085.0 
Total$2,510.6 $2,566.5 $2,569.1 
Property, plant and equipment, net:December 31, 2024December 31, 2023
United States$155.6 $171.8 
Sweden32.4 39.6 
Czech Republic23.2 24.3 
China21.3 22.1 
Mexico15.8 17.5 
All other (each country individually less than 5% of total long-lived assets)28.7 34.3 
Total$277.0 $309.6